CLRB

About Cellectar Biosciences INC NEW (CLRB) Stock

Cellectar Biosciences INC NEW (CLRB) closed the 2026-09-18 session at $2.38, down 0.83% versus the previous close (-0.02). The stock opened at $2.39 and traded between $2.37 and $2.44 during that session. Session trading volume was 74K shares. The volume-weighted average price (VWAP) is $2.40.

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. The products under development include Iopofosine, CLR 121125 ,CLR 121225 and others. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

Cellectar Biosciences INC NEW has a market capitalization of $22.7 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. CLRB is listed on the XNAS exchange. The company employs approximately 11 people. Cellectar Biosciences INC NEW is headquartered in FLORHAM PARK, NJ. The recorded listing date is 2005-04-19.

On this page you can find market CLRB stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.

Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.